BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Vitrolife (Publ): Embryoglue(R) Increases the Chances of the Infertile Having Children


7/6/2011 10:24:15 AM

GÖTEBORG, Sweden--(BUSINESS WIRE)-- A study which shows that significantly more (63%) patients had children when EmbryoGlue® was used, compared with the control group, was presented at the ongoing ESHRE conference in Stockholm. Vitrolife’s patented medium EmbryoGlue® is used when reintroducing embryos in connection with assisted fertilization. We have now shown that EmbryoGlue® results in more babies being born compared with traditional products, irrespective of the day when the embryos are reintroduced, says Dr. Basak Balaban, who works at the American Hospital in Istanbul, Turkey.

Read at BioSpace.com

Vitrolife
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->